Remove Analysis Remove Definition Remove Healthcare
article thumbnail

Four Use Cases Proving the Benefits of Metadata-Driven Automation

erwin

That’s time needed and better used for data analysis. Metadata-Driven Automation in the Pharmaceutical Industry. One global pharmaceutical giant headquartered in the United States experienced such issues until it adopted metadata-driven automation. ROI on the automation solutions was realized within the first year.

article thumbnail

Redefining clinical trials: Adopting AI for speed, volume and diversity

IBM Big Data Hub

Our analysis of the voluntarily reported Form FDA 1572 BMIS database reveals a potential lack of sustainability in the investigator pool, both in the United States (US) and globally (Exhibit 2). IBM is at the forefront of adopting AI for the pharmaceutical business, showcasing our commitment to refining this domain.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

Determining the scope of each of these exemptions and how they apply to a company will require careful analysis. As a starting point, determine whether the company qualifies as a business under the CCPA’s definition or if it may be subject to the CCPA by its relationships with for-profit businesses. Non-profit Exemption.

Privacy 45
article thumbnail

Data Intelligence and Its Role in Combating Covid-19

erwin

Privately it will come from hospitals, labs, pharmaceutical companies, doctors and private health insurers. These numerous data types and data sources most definitely weren’t designed to work together. Data lineage to support impact analysis. As a result, the data may be compromised, rendering faulty analyses and insights.

Metadata 122
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

Determining the scope of each of these exemptions and how they apply to a company will require careful analysis. As a starting point, determine whether the company qualifies as a business under the CCPA’s definition or if it may be subject to the CCPA by its relationships with for-profit businesses. Non-profit Exemption.

Privacy 40
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

Determining the scope of each of these exemptions and how they apply to a company will require careful analysis. As a starting point, determine whether the company qualifies as a business under the CCPA’s definition or if it may be subject to the CCPA by its relationships with for-profit businesses. Non-profit Exemption.

Privacy 40
article thumbnail

Regulatory Update: NAIC Summer 2021 National Meeting

Data Matters

Among other matters, the revised bond factors establish a more granular rating analysis by expanding the number of bond designation categories from the previous six categories to 20 categories. The passporting process is facilitated through the Reinsurance Financial Analysis (E) Working Group (ReFAWG).